๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Tolvaptan - Medicines in Ireland

9 authorised products containing Tolvaptan, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 9 authorised medicines
MedicineActive substanceLicence holderStatus
Jinarc 15 mg tablets
EU/1/15/1000/001-002
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Jinarc 15 mg tablets + Jinarc 45 mg tablets
EU/1/15/1000/005-007
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Jinarc 30 mg tablets
EU/1/15/1000/003-004
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Jinarc 30 mg tablets + Jinarc 60 mg tablets
EU/1/15/1000/008-010
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Jinarc 30 mg tablets + Jinarc 90 mg tablets
EU/1/15/1000/011-013
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Samsca 15 mg Tablet
EU/1/09/539/1-2
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Samsca 30 mg Tablet
EU/1/09/539/3-4
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Tolvaptan Accord 7.5 mg Tablet
EU/1/23/1719/001-004
Tolvaptan Accord Healthcare S.L.U. โ€”
Tolvaptan Ascend 7.5 mg tablets
PA23429/006/001
Tolvaptan Ascend GmbH Not marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.